BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24333132)

  • 1. EGFR inhibition by pentacyclic triterpenes exhibit cell cycle and growth arrest in breast cancer cells.
    Sathya S; Sudhagar S; Sarathkumar B; Lakshmi BS
    Life Sci; 2014 Jan; 95(1):53-62. PubMed ID: 24333132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25-Methoxyhispidol A, a novel triterpenoid of Poncirus trifoliata, inhibits cell growth via the modulation of EGFR/c-Src signaling pathway in MDA-MB-231 human breast cancer cells.
    Chung HJ; Park EJ; Pyee Y; Hua Xu G; Lee SH; Kim YS; Lee SK
    Food Chem Toxicol; 2011 Nov; 49(11):2942-6. PubMed ID: 21782877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
    Petty WJ; Dragnev KH; Memoli VA; Ma Y; Desai NB; Biddle A; Davis TH; Nugent WC; Memoli N; Hamilton M; Iwata KK; Rigas JR; Dmitrovsky E
    Clin Cancer Res; 2004 Nov; 10(22):7547-54. PubMed ID: 15569985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
    Ferrer-Soler L; Vazquez-Martin A; Brunet J; Menendez JA; De Llorens R; Colomer R
    Int J Mol Med; 2007 Jul; 20(1):3-10. PubMed ID: 17549382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro.
    Jing B; Liu M; Yang L; Cai HY; Chen JB; Li ZX; Kou X; Wu YZ; Qin DJ; Zhou L; Jin J; Lei H; Xu HZ; Wang WW; Wu YL
    Acta Pharmacol Sin; 2018 Mar; 39(3):492-498. PubMed ID: 29168472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant, antiproliferative, and pro-apoptotic capacities of pentacyclic triterpenes found in the skin of olives on MCF-7 human breast cancer cells and their effects on DNA damage.
    Allouche Y; Warleta F; Campos M; Sánchez-Quesada C; Uceda M; Beltrán G; Gaforio JJ
    J Agric Food Chem; 2011 Jan; 59(1):121-30. PubMed ID: 21142067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
    Zhao CH; Zhang CL; Shi JJ; Hou XY; Feng B; Zhao LX
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4500-4. PubMed ID: 26343825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells.
    Sgambato A; Camerini A; Faraglia B; Ardito R; Bianchino G; Spada D; Boninsegna A; Valentini V; Cittadini A
    J Cell Physiol; 2004 Oct; 201(1):97-105. PubMed ID: 15281092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1.
    Altiok N; Mezzadra H; Patel P; Koyuturk M; Altiok S
    Breast Cancer Res Treat; 2008 May; 109(2):315-23. PubMed ID: 17638069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CS-1 on A431 cell proliferation, cell cycle, and epidermal growth factor receptor signal transduction.
    Du H; Xu B; Wu C; Li M; Ran F; Cai S; Cui J
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):136-46. PubMed ID: 22193592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
    Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
    Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.